KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 204 filers reported holding KURA ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is 0.31 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $7,535,747 | +2.3% | 616,169 | +3.8% | 0.48% | +10.3% |
| Q4 2022 | $7,366,092 | -3.3% | 593,561 | +9.1% | 0.44% | -1.8% |
| Q4 2021 | $7,618,000 | -46.1% | 544,173 | -27.9% | 0.44% | -46.9% |
| Q3 2021 | $14,143,000 | +52.6% | 755,121 | +69.9% | 0.84% | +56.9% |
| Q2 2021 | $9,265,000 | +294.1% | 444,372 | +434.3% | 0.53% | +278.7% |
| Q1 2021 | $2,351,000 | -40.3% | 83,164 | -31.1% | 0.14% | -40.0% |
| Q4 2020 | $3,941,000 | -42.9% | 120,677 | -46.4% | 0.24% | -54.1% |
| Q3 2020 | $6,902,000 | -30.7% | 225,259 | -63.1% | 0.51% | -18.5% |
| Q2 2020 | $9,959,000 | +130.1% | 610,979 | +147.0% | 0.63% | +62.7% |
| Q3 2018 | $4,329,000 | +28.4% | 247,385 | +33.6% | 0.39% | +79.5% |
| Q2 2018 | $3,371,000 | – | 185,195 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,849,947 | $16,871,517 | 9.37% |
| Prosight Management, LP | 1,932,456 | $17,623,999 | 5.58% |
| ACUTA CAPITAL PARTNERS, LLC | 702,093 | $6,403,088 | 4.29% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 350,445 | $3,196,058 | 3.93% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 7,335,845 | $66,902,906 | 3.62% |
| Affinity Asset Advisors, LLC | 856,535 | $7,811,599 | 2.20% |
| TCG Crossover Management, LLC | 1,423,642 | $12,983,615 | 1.91% |
| EcoR1 Capital, LLC | 5,806,871 | $52,958,664 | 1.79% |
| BVF INC/IL | 6,730,983 | $61,386,565 | 1.66% |
| DAFNA Capital Management LLC | 550,784 | $5,023,150 | 1.56% |